TOKYO, Mar 25 (Pulse News Wire) – Chordia Therapeutics Inc. (190A.T) reported the massive exercise of its ninth tranche warrants (with adjustment clause) from March 2 to March 25, 2026.
During this period, 1,585,000 shares were delivered based on the exercise of 1,585,000 warrants out of a total issuance of 2,000,000 warrants. As of March 25, 2026, there remain 415,000 unexercised warrants.
In detail, the warrant exercises occurred on multiple days within the reporting period. Notably, significant exercises took place on March 2, March 5, March 13, and March 25, with deliveries of 158,500, 114,200, 117,200, and 118,165 shares respectively.
The cumulative number of exercised warrants reached 1,585,000 during this timeframe.
🟢 Confidence: High AI-translated content.